Rein Therapeutics's total assets for Q3 2025 were $53.71M, a decrease of -6.56% from the previous quarter. RNTX total liabilities were $7.52M for the fiscal quarter, a -86.20% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.